Rahul D. Ballal - Net Worth and Insider Trading
Rahul D. Ballal Net Worth
The estimated net worth of Rahul D. Ballal is at least $2 Million dollars as of 2024-12-26. Rahul D. Ballal is the CEO of Imara Inc and owns about 120,696 shares of Imara Inc (IMRA) stock worth over $762,799. Rahul D. Ballal is the Director of Enliven Therapeutics Inc and owns about 22,341 shares of Enliven Therapeutics Inc (ELVN) stock worth over $507,364. Rahul D. Ballal is also the Director of Agios Pharmaceuticals Inc and owns about 7,992 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $274,685. Details can be seen in Rahul D. Ballal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rahul D. Ballal has not made any transactions after 2024-11-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rahul D. Ballal
Rahul D. Ballal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rahul D. Ballal owns 3 companies in total, including Imara Inc (IMRA) , Agios Pharmaceuticals Inc (AGIO) , and Enliven Therapeutics Inc (ELVN) .
Click here to see the complete history of Rahul D. Ballal’s form 4 insider trades.
Insider Ownership Summary of Rahul D. Ballal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IMRA | Imara Inc | 2023-01-30 | director & President & CEO |
| AGIO | Agios Pharmaceuticals Inc | 2024-11-08 | director |
| ELVN | Enliven Therapeutics Inc | 2024-10-08 | director & President & CEO |
Rahul D. Ballal Latest Holdings Summary
Rahul D. Ballal currently owns a total of 3 stocks. Among these stocks, Rahul D. Ballal owns 120,696 shares of Imara Inc (IMRA) as of January 30, 2023, with a value of $762,799 and a weighting of 49.38%. Rahul D. Ballal owns 22,341 shares of Enliven Therapeutics Inc (ELVN) as of October 8, 2024, with a value of $507,364 and a weighting of 32.84%. Rahul D. Ballal also owns 7,992 shares of Agios Pharmaceuticals Inc (AGIO) as of November 8, 2024, with a value of $274,685 and a weighting of 17.78%.
Latest Holdings of Rahul D. Ballal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IMRA | Imara Inc | 2023-01-30 | 120,696 | 6.32 | 762,799 |
| ELVN | Enliven Therapeutics Inc | 2024-10-08 | 22,341 | 22.71 | 507,364 |
| AGIO | Agios Pharmaceuticals Inc | 2024-11-08 | 7,992 | 34.37 | 274,685 |
Holding Weightings of Rahul D. Ballal
Rahul D. Ballal Form 4 Trading Tracker
According to the SEC Form 4 filings, Rahul D. Ballal has made a total of 3 transactions in Imara Inc (IMRA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Imara Inc is the sale of 11,313 shares on January 30, 2023, which brought Rahul D. Ballal around $44,234.
According to the SEC Form 4 filings, Rahul D. Ballal has made a total of 5 transactions in Enliven Therapeutics Inc (ELVN) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Enliven Therapeutics Inc is the sale of 10,420 shares on October 8, 2024, which brought Rahul D. Ballal around $293,531.
According to the SEC Form 4 filings, Rahul D. Ballal has made a total of 1 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 20,000 shares on November 8, 2024, which brought Rahul D. Ballal around $1 Million.
Insider Trading History of Rahul D. Ballal
- 1
Rahul D. Ballal Trading Performance
Rahul D. Ballal Ownership Network
Rahul D. Ballal Owned Company Details
What does Imara Inc do?
Who are the key executives at Imara Inc?
Rahul D. Ballal is the director & President & CEO of Imara Inc. Other key executives at Imara Inc include See Remarks Michael Gray , 10 percent owner Braden Michael Leonard , and 10 percent owner Ra Capital Healthcare Fund Lp .
Imara Inc (IMRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Imara Inc (IMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Imara Inc Insider Transactions
Rahul D. Ballal Mailing Address
Above is the net worth, insider trading, and ownership report for Rahul D. Ballal. You might contact Rahul D. Ballal via mailing address: 116 Huntington Avenue, 6th Floor, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
